208 related articles for article (PubMed ID: 12107213)
1. Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study.
Sklar CA; Mertens AC; Mitby P; Occhiogrosso G; Qin J; Heller G; Yasui Y; Robison LL
J Clin Endocrinol Metab; 2002 Jul; 87(7):3136-41. PubMed ID: 12107213
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor.
Ergun-Longmire B; Mertens AC; Mitby P; Qin J; Heller G; Shi W; Yasui Y; Robison LL; Sklar CA
J Clin Endocrinol Metab; 2006 Sep; 91(9):3494-8. PubMed ID: 16822820
[TBL] [Abstract][Full Text] [Related]
3. Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS.
Woodmansee WW; Zimmermann AG; Child CJ; Rong Q; Erfurth EM; Beck-Peccoz P; Blum WF; Robison LL;
Eur J Endocrinol; 2013 Apr; 168(4):565-73. PubMed ID: 23359434
[TBL] [Abstract][Full Text] [Related]
4. Influence of growth hormone therapy on the occurrence of a second neoplasm in survivors of childhood cancer.
Thomas-Teinturier C; Oliver-Petit I; Pacquement H; Fresneau B; Allodji RS; Veres C; Bolle S; Berchery D; Demoor-Goldschmidt C; Haddy N; Diallo I; de Vathaire F
Eur J Endocrinol; 2020 Oct; 183(4):471-480. PubMed ID: 32738133
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the childhood cancer survivor study.
Patterson BC; Chen Y; Sklar CA; Neglia J; Yasui Y; Mertens A; Armstrong GT; Meadows A; Stovall M; Robison LL; Meacham LR
J Clin Endocrinol Metab; 2014 Jun; 99(6):2030-7. PubMed ID: 24606096
[TBL] [Abstract][Full Text] [Related]
6. Factors that affect final height and change in height standard deviation scores in survivors of childhood cancer treated with growth hormone: a report from the childhood cancer survivor study.
Brownstein CM; Mertens AC; Mitby PA; Stovall M; Qin J; Heller G; Robison LL; Sklar CA
J Clin Endocrinol Metab; 2004 Sep; 89(9):4422-7. PubMed ID: 15356041
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone treatment and risk of recurrence or development of secondary neoplasms in survivors of pediatric brain tumors.
Wang ZF; Chen HL
J Clin Neurosci; 2014 Dec; 21(12):2155-9. PubMed ID: 25065848
[TBL] [Abstract][Full Text] [Related]
8. GH replacement therapy and second neoplasms in adult survivors of childhood cancer: a retrospective study from a single institution.
Brignardello E; Felicetti F; Castiglione A; Fortunati N; Matarazzo P; Biasin E; Sacerdote C; Ricardi U; Fagioli F; Corrias A; Arvat E
J Endocrinol Invest; 2015 Feb; 38(2):171-6. PubMed ID: 25344310
[TBL] [Abstract][Full Text] [Related]
9. GH replacement does not increase the risk of recurrence in patients with craniopharyngioma.
Karavitaki N; Warner JT; Marland A; Shine B; Ryan F; Arnold J; Turner HE; Wass JA
Clin Endocrinol (Oxf); 2006 May; 64(5):556-60. PubMed ID: 16649976
[TBL] [Abstract][Full Text] [Related]
10. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort.
Meadows AT; Friedman DL; Neglia JP; Mertens AC; Donaldson SS; Stovall M; Hammond S; Yasui Y; Inskip PD
J Clin Oncol; 2009 May; 27(14):2356-62. PubMed ID: 19255307
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal follow-up of adult survivors of Ewing sarcoma: A report from the Childhood Cancer Survivor Study.
Marina NM; Liu Q; Donaldson SS; Sklar CA; Armstrong GT; Oeffinger KC; Leisenring WM; Ginsberg JP; Henderson TO; Neglia JP; Stovall MA; Yasui Y; Randall RL; Geller DS; Robison LL; Ness KK
Cancer; 2017 Jul; 123(13):2551-2560. PubMed ID: 28222219
[TBL] [Abstract][Full Text] [Related]
12. Perceptions of future health and cancer risk in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.
Gibson TM; Li C; Armstrong GT; Srivastava DK; Leisenring WM; Mertens A; Brinkman TM; Diller L; Nathan PC; Hudson MM; Robison LL
Cancer; 2018 Aug; 124(16):3436-3444. PubMed ID: 29938398
[TBL] [Abstract][Full Text] [Related]
13. Cancer risk following growth hormone use in childhood: implications for current practice.
Ogilvy-Stuart AL; Gleeson H
Drug Saf; 2004; 27(6):369-82. PubMed ID: 15144231
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of growth hormone replacement therapy in survivors of childhood acute lymphoblastic leukemia.
Leung W; Rose SR; Zhou Y; Hancock ML; Burstein S; Schriock EA; Lustig R; Danish RK; Evans WE; Hudson MM; Pui CH
J Clin Oncol; 2002 Jul; 20(13):2959-64. PubMed ID: 12089225
[TBL] [Abstract][Full Text] [Related]
15. Late recurrence in pediatric cancer: a report from the Childhood Cancer Survivor Study.
Wasilewski-Masker K; Liu Q; Yasui Y; Leisenring W; Meacham LR; Hammond S; Meadows AT; Robison LL; Mertens AC
J Natl Cancer Inst; 2009 Dec; 101(24):1709-20. PubMed ID: 19966206
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes in survivors of neuroblastoma: a report from the Childhood Cancer Survivor Study.
Laverdière C; Liu Q; Yasui Y; Nathan PC; Gurney JG; Stovall M; Diller LR; Cheung NK; Wolden S; Robison LL; Sklar CA
J Natl Cancer Inst; 2009 Aug; 101(16):1131-40. PubMed ID: 19648511
[TBL] [Abstract][Full Text] [Related]
17. Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement.
Gleeson HK; Stoeter R; Ogilvy-Stuart AL; Gattamaneni HR; Brennan BM; Shalet SM
J Clin Endocrinol Metab; 2003 Aug; 88(8):3682-9. PubMed ID: 12915655
[TBL] [Abstract][Full Text] [Related]
18. Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort.
Essig S; Li Q; Chen Y; Hitzler J; Leisenring W; Greenberg M; Sklar C; Hudson MM; Armstrong GT; Krull KR; Neglia JP; Oeffinger KC; Robison LL; Kuehni CE; Yasui Y; Nathan PC
Lancet Oncol; 2014 Jul; 15(8):841-51. PubMed ID: 24954778
[TBL] [Abstract][Full Text] [Related]
19. Mortality among 5-year survivors of cancer diagnosed during childhood or adolescence in British Columbia, Canada.
MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Abanto ZU; McBride ML
Pediatr Blood Cancer; 2007 Apr; 48(4):460-7. PubMed ID: 16767717
[TBL] [Abstract][Full Text] [Related]
20. Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.
Morton LM; Sampson JN; Armstrong GT; Chen TH; Hudson MM; Karlins E; Dagnall CL; Li SA; Wilson CL; Srivastava DK; Liu W; Kang G; Oeffinger KC; Henderson TO; Moskowitz CS; Gibson TM; Merino DM; Wong JR; Hammond S; Neglia JP; Turcotte LM; Miller J; Bowen L; Wheeler WA; Leisenring WM; Whitton JA; Burdette L; Chung C; Hicks BD; Jones K; Machiela MJ; Vogt A; Wang Z; Yeager M; Neale G; Lear M; Strong LC; Yasui Y; Stovall M; Weathers RE; Smith SA; Howell R; Davies SM; Radloff GA; Onel K; Berrington de González A; Inskip PD; Rajaraman P; Fraumeni JF; Bhatia S; Chanock SJ; Tucker MA; Robison LL
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
